Cargando…
Tamoxifen and Src kinase inhibitors as neuroprotective/neuroregenerative drugs after spinal cord injury
Spinal cord injury (SCI) is a devastating condition that produces significant changes in the lifestyle of patients. Many molecular and cellular events are triggered after the initial physical impact to the cord. Two major phases have been described in the field of SCI: an acute phase and late phase....
Autores principales: | Salgado, Iris K., Torrado, Aranza I., Santiago, Jose M., Miranda, Jorge D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396099/ https://www.ncbi.nlm.nih.gov/pubmed/25878585 http://dx.doi.org/10.4103/1673-5374.153685 |
Ejemplares similares
-
Tamoxifen: an FDA approved drug with neuroprotective effects for spinal cord injury recovery
por: Colón, Jennifer M., et al.
Publicado: (2016) -
The leading edge: Emerging neuroprotective and neuroregenerative cell‐based therapies for spinal cord injury
por: Ahuja, Christopher S., et al.
Publicado: (2020) -
Long-term treatment with PP2 after spinal cord injury resulted in functional locomotor recovery and increased spared tissue
por: Rosas, Odrick R., et al.
Publicado: (2014) -
Integrated Neuroregenerative Techniques for Plasticity of the Injured Spinal Cord
por: Leemhuis, Erik, et al.
Publicado: (2022) -
Practical application of the neuroregenerative properties of ketamine: real world treatment experience
por: Henderson, Theodore A.
Publicado: (2016)